載入...
Do immune checkpoint inhibitors need new studies methodology?
Immune checkpoint inhibitors (ICI) have widely reshaped the treatment paradigm of advanced cancer patients. Although multiple studies are currently evaluating these drugs as monotherapies or in combination, the choice of the most accurate statistical methods, endpoints and clinical trial designs to...
Na minha lista:
| 發表在: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994495/ https://ncbi.nlm.nih.gov/pubmed/29951307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.131 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|